scholarly journals A Phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma

Cancer ◽  
1997 ◽  
Vol 80 (1) ◽  
pp. 42-49 ◽  
Author(s):  
Hideki Kimura ◽  
Yutaka Yamaguchi
Keyword(s):  
Lung Carcinoma ◽  
Randomized Study ◽  
Killer Cell ◽  
Interleukin 2 ◽  
Phase Iii ◽  
Lymphokine Activated Killer Cell ◽  
Cell Immunotherapy ◽  
Primary Lung Carcinoma ◽  
Noncurative Resection

Generation of lymphokine-activated killer cell activity by low-dose recombinant interleukin-2 and tumor cells

1990 ◽  
Vol 128 (2) ◽  
pp. 516-527 ◽  
Author(s):  
Saburo Yamamoto ◽  
Dave S.B. Hoon ◽  
Peter Chandler ◽  
Ingrid Schmid ◽  
Reiko F. Irie
Keyword(s):  
Tumor Cells ◽  
Low Dose ◽  
Killer Cell ◽  
Interleukin 2 ◽  
Cell Activity ◽  
Lymphokine Activated Killer Cell ◽  
Killer Cell Activity ◽  
Recombinant Interleukin 2

Intraperitoneal Lymphokine-Activated Killer Cell/Interleukin-2 Therapy in Patients With Intra- abdominal Cancer: Immunologic Considerations

1989 ◽  
Vol 81 (8) ◽  
pp. 602-611 ◽  
Author(s):  
Walter J. Urba ◽  
Jeffrey W. Clark ◽  
Ronald G. Steis ◽  
Michael A. Bookman ◽  
John W. Smith ◽  
...  
Keyword(s):  
Killer Cell ◽  
Interleukin 2 ◽  
Lymphokine Activated Killer Cell

scholarly journals Randomized Study of Autologous Cytokine-Induced Killer Cell Immunotherapy in Metastatic Renal Carcinoma

2012 ◽  
Vol 18 (6) ◽  
pp. 1751-1759 ◽  
Author(s):  
Liang Liu ◽  
Weihong Zhang ◽  
Xiuying Qi ◽  
Hui Li ◽  
Jinpu Yu ◽  
...  
Keyword(s):  
Renal Carcinoma ◽  
Randomized Study ◽  
Killer Cell ◽  
Cell Immunotherapy
Sign in / Sign up

Export Citation Format

Share Document